Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: February 2008

Bisphosphonates and Osteonecrosis of the Jaw

01 February 2008 | Irish Medicines Board

Further Class Review by the Pharmacovigilance Working Party (PhVWP) Bisphosphonates are a class of medicinal substances approved for various indications related to their inhibitory effect on bone resorption in certain malignant and benign diseases, including osteoporosis. For detailed information on... Read more

Rispone Oral Solution and Tablets

01 February 2008 | New Presentations

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Risperidone 1mg/ml oral solution and 0.5mg tablet. Description: Clear, colourless solution and red oval film-coated tablet with breaking notch. Presentation: 1mg/ml-100ml, €59.46; 0.5mg-20, €11.26. Indications: Solution: The treatment of... Read more

Rebetol Oral Solution

01 February 2008 | New Presentations

Prescription. HT. Sport Permitted. Schering-Plough wishes to announce the launch of Rebetol (ribavirin) 40mg/ml Oral Solution. Rebetol Oral Solution is a clear, colourless to pale or light yellow oral solution intended for use in a combination regimen with interferon alfa-2b... Read more

Exelon Transdermal Patch

01 February 2008 | New Presentations

Prescription. GMS. Sport Permitted. Novartis Ireland is pleased to announce the launch of once daily Exelon Transdermal Patch, for the first line treatment of mild to moderately severe Alzheimer’s dementia.... Read more

Nebivolol (Nebilet) is Now Licensed for the Treatment of Hypertension in the USA

01 February 2008 | New Clinical Evidence

In New York on December 18th 2007, Forest Laboratories, Inc., and Mylan Inc., announced that the novel beta blocker nebivolol (Bystolic) is now licensed for the treatment of hypertension. Nebivolol, trade name Nebilet in Ireland, is already approved and successfully... Read more

Avastin approved in Europe for first-line treatment of patients with advanced kidney cancer

01 February 2008 | New Clinical Evidence

Roche Products (Ireland) Ltd., wish to announce that Avastin (bevacizumab) is approved in EU for the first-line treatment of patients with renal cell carcinoma, the most common form of advanced kidney cancer. Treatment options for patients with kidney cancer are... Read more

Efficacy and Tolerability of new Once daily Exelon Transdermal Patch

01 February 2008 | New Clinical Evidence

Novartis Ireland wish to announce the launch of once daily Exelon transdermal patch, for the first line treatment of mild to moderately severe Alzheimer’s dementia (AD).... Read more

Aclasta Once yearly for Treatment of Postmenopausal Osteoporosis

01 February 2008 | New Clinical Evidence

Novartis Ireland are delighted to announce the availability of Aclasta (zoledronic acid) for the treatment of postmenopausal osteoporosis. Bisphosphonates, the most commonly used treatment for established osteoporosis, inhibit osteoclast-mediated bone resorption and reduce the risk of fracture. However, adherence to... Read more

Products Withdrawn in Ireland in the last 12 Months

01 February 2008 | Discontinued Products

The majority of withdrawals have been due to commercial rationalisation decisions.Products highlighted in bold apply to the current month.... Read more

Product Discontinuation Announcements

01 February 2008 | Discontinued Products

Byfluc, Calcort, Gyno-Pevaryl, 1 Combipak, Motival, MST Continus 200mg, Vibramycine capsules 50mg, Zerit 15mg have been discontinued.... Read more

Gygel to replace Ortho-Creme

01 February 2008 | New this Month, Discontinued Products

Janssen-Cilag Ltd would like to inform you that they have discontinued Gyno- Ortho-Crème (nonoxinol-9) at the end of January 2008. They are pleased to announce that an alternative nonoxinol-9 based spermicidal product will be available from Marlborough Pharmaceuticals Ltd. This... Read more

Efexor XL, Tazicin, Meningitec Suspension

01 February 2008 | New this Month

Wyeth Pharmaceuticals Ltd is pleased to advise you that Efexor XL 37.5mg is now available for the treatment of panic disorder (see New Clinical Evidence). They would also like to inform you that Tazocin (piperacillin/tazobactam) has been reformulated. Tazocin new... Read more

Tevax

01 February 2008 | New Products

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Alfuzosin hydrochloride10mg. Description: White, round, bevelled-edges, prolonged releasetablet. Presentation: 30, €18.78. Indications: Moderate to severe functional symptoms of benignprostatic hyperplasia (BPH).... Read more

Rispeva

01 February 2008 | New Products

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Risperidone 1mg, 2mg, 3mg, 4mg. Description: White, pale brown, yellow or pale green respectively, round, bevelled biconvex film-coated tablets, scored and marked with RIS above the score line... Read more

Ecalta

01 February 2008 | New Products

Company: Pfizer Healthcare Ireland. Legal category: Hospital. Sport Permitted. Active ingredient: Anidulafungin 100mg. The reconstituted solution contains 3.33mg/ml anidulafungin and the diluted solution contains 0.36mg/ml anidulafungin. Description: 100mg powder and 30ml solvent for concentrate for solution for infusion in vials.... Read more

Celsentri

01 February 2008 | New Products

Company: Pfizer Healthcare Ireland. Legal category: Hospital. Sport Permitted. Active ingredient: Maraviroc 150mg, 300mg. Description: Blue, biconvex, oval film-coated tablets marked Pfizer on one side and MVC150 or MVC300 on reverse. Presentation: 60, €966. Indications: As part of an antiretroviral... Read more

Advagraf

01 February 2008 | New Products

Company: Astellas Pharma Co. Ltd. Legal category: Prescription. HT. Sport Permitted. Active ingredient: Tacrolimus 0.5mg, 1mg, 5mg. Description: Yellow-orange, white-orange, greyish red-orange gelatin capsules imprinted in red with 0.5mg, 1mg, 5mg on the capsule cap and *647, *677, *687 respectively... Read more

Efexor XL Approved for the Treatment of Panic Disorder

01 February 2008 | New Clinical Evidence

Wyeth is pleased to announce the launch of Efexor XL 37.5mg for use in Panic Disorder, with or without agoraphobia. Panic disorder is characterised by recurrent, unexpected panic attacks; i.e., a discrete period of intense fear or discomfort in the... Read more

Mircera once every four weeks for dialysis patients

01 February 2008 | New Clinical Evidence

Pivotal Mircera study first to convert dialysis patients from frequent dosing directly to once every four weeks. A pivotal study published in the Lancet has shown that dialysis patients can be effectively switched from frequently dosed anaemia drugs to an... Read more